Senate health panels face major turnover in midterms
Upcoming midterm elections could reshape the Senate committees that write health policy, with at least five Finance Committee Republicans departing.
Clinical AI, drug discovery, devices, and regulatory approvals.
Upcoming midterm elections could reshape the Senate committees that write health policy, with at least five Finance Committee Republicans departing.
A new analysis of U.S. prescribing data finds a dramatic rise in GLP-1 use among children with obesity, while the author urges caution and systemic change.
A 12-week trial suggests creatine alone can increase muscle and strength, with larger gains when paired with exercise and diet.
A preclinical study identifies UBE2N as a natural protective enzyme whose decline may allow fatty liver disease to advance into the more severe condition MASH.
The latest AI Prognosis edition from STAT signals growing attention to what health tech leaders are saying in Washington policy circles.
An NYU transplant surgeon says early data support using GLP-1 drugs in teens and calls for expanding access to children under 12.
Elevance Health will require hospitals to report where care is delivered and pay less for off-campus services, a step toward site-neutral payments that hospitals oppose.
AMN Healthcare's annual report shows overall physician starting pay rose to $419,000, with gastroenterology topping the list.
A new study suggests long Covid, ME/CFS, PTSD, and other conditions may disrupt common biological pathways, explaining overlapping symptoms.
A study reveals the essential amino acid leucine can increase cellular energy production by shielding mitochondrial proteins from degradation, linking diet to metabolism.
A public-health researcher argues that fraternity hazing rituals involving feces, vomit, and spoiled food create hidden infectious-disease outbreaks on campuses.
The biotech appoints a former BridgeBio CMO, as STAT's Pharmalot column tracks industry personnel moves.
Eli Lilly is selling drugs directly to patients in Australia, cutting out traditional pharmacies.
The outbreak has become the fastest-growing in history, with insecurity and unpaid workers hampering containment.
A MedPage Today podcast covers three unrelated healthcare stories: a controversial AI-assisted research boot camp, proposed rollbacks to resident work-hour protections, and a potential new definition for measles deaths.
Kodiak’s long-acting eye drug matched Eylea in a pivotal trial, while Hengrui’s obesity-drug pact with Novo shows the continued pull of Chinese biotech assets.
A national study finds modest gains in young people starting addiction medications, yet six-month retention remains rare and may be declining.
The geneticist who linked BRCA mutations to hereditary breast and ovarian cancer reflects on decades of near-miss Nobel speculation.